Immunogenicity Study of Antibody Persistence and Booster Effect of PENTAXIM™ at 18 Months in Healthy Argentinean Infants

Clinical trial NCT00303316 · COMPLETED

Trial details

NCT number: NCT00303316
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diphtheria Tetanus Pertussis Poliomyelitis Hepatitis B

Start date: 2006-02-01
Primary completion: 2007-04-01
Enrollment: 458

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.